Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Telemonitoring for High-risk Pregnancies in an International Context (PregnaDigit EU): a Hybrid Type 2 Study

NCT07191236 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT07191236
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07191236 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Telemonitoring for High-risk Pregnancies in an International Context (PregnaDigit EU): a Hybrid Type 2 Study
Lead sponsor
UMC Utrecht
Phase
Observational
Overall status
Enrolling by invitation
Start date
February 17, 2025
Completion date
February 29, 2028
Enrollment
450 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

digital health, pregnancy complications, telemedicine